P608Characteristics of patients with heart failure prescribed sacubitril/valsartan in the primary care and cardiology settings in Germany
Sara Bruce Wirta(Novartis (Switzerland)), Bogdan Balas(Roche (Switzerland)), Raymond G. Schlienger(Novartis (Switzerland)), Markus Dworak(Novartis (Germany)), Sven Klebs(Novartis (Germany)), J. Engelhard(IQVIA (United Kingdom)), Matthias Schindler(University of Bern), F Calado(Novartis (Switzerland)), Catia C Proenca, Stefanie S Grunow
Cited by 0
Related Papers
Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study
|The Lancet Child & Adolescent Health|2017|171
Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
|European Journal of Clinical Pharmacology|2014|162
Real-World Treatment Patterns of Sacubitril/Valsartan: A Longitudinal Cohort Study in Germany
|European Journal of Heart Failure|2019|66
Burden of heart failure on caregivers in China: results from a cross-sectional survey
|Drug Design Development and Therapy|2018|48